the end of the day, page-22

re: the end of the day- drunk A couple of reasons/ guesses, drunk, why they went down after this placement.
1. Disappointment that the announcement wasn't what people expected or wanted. I think this company has gone into a trading halt only 3 times in its history so folk probably expected something big.
2.There are so many momentum traders out there buying and selling for technical reasons only. (The firm splattering its ads across my hc screen obviously encourages this type of investment). The announcement offered little for those interested only in quick rises and falls
3 Every placement waters down the PBI shareholding, although in this case, the effects are slight and the leverage offered by PBI is still considerable.
What will get the sp up and away? In the short term. my money is on the epidural product, although there is still the prospect of announcements re. sales of their existing products being launched in Europe. Perhaps the market now wants something more than an announcement or two about products being sold under licence for the Americans, however profitable that may be.
IMO what's needed is for PBI to prove that it has developed something themselves and the announcement about the Israeli link didn't really do that. So much depends on Horley being able to meet that Dec 31 deadline. If there is no news on epidural sales by then, I fear the sp will go down below 20 cents. If they announce just 1 or 2 sales, the cynics will say it's a contrived arrangement to get the bonus shares.
In fact, I fear that the market won't be happy unless they hear of 3 or 4 sales of the new product. Afterall, with PBI's presence in Australia, China the UK and now Israel, they should have the ear of enough potential buyers to do that - but is the product good enough?